rs35502837

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000491967.2(SMARCB1):​n.968C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0255 in 667,950 control chromosomes in the GnomAD database, including 288 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 39 hom., cov: 32)
Exomes 𝑓: 0.027 ( 249 hom. )

Consequence

SMARCB1
ENST00000491967.2 non_coding_transcript_exon

Scores

3

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -1.06

Publications

3 publications found
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
SMARCB1 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, autosomal dominant 15
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • rhabdoid tumor predisposition syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • SMARCB1-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
  • familial multiple meningioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schwannomatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-23801386-C-A is Benign according to our data. Variant chr22-23801386-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 133393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0209 (3181/152324) while in subpopulation NFE AF = 0.0294 (2002/68024). AF 95% confidence interval is 0.0284. There are 39 homozygotes in GnomAd4. There are 1613 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3181 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCB1NM_003073.5 linkc.500+305C>A intron_variant Intron 4 of 8 ENST00000644036.2 NP_003064.2 Q12824-1
SMARCB1NM_001362877.2 linkc.554+251C>A intron_variant Intron 4 of 8 NP_001349806.1
SMARCB1NM_001317946.2 linkc.527+251C>A intron_variant Intron 4 of 8 NP_001304875.1 G5E975Q9H836
SMARCB1NM_001007468.3 linkc.473+305C>A intron_variant Intron 4 of 8 NP_001007469.1 Q12824-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCB1ENST00000644036.2 linkc.500+305C>A intron_variant Intron 4 of 8 NM_003073.5 ENSP00000494049.2 Q12824-1

Frequencies

GnomAD3 genomes
AF:
0.0209
AC:
3182
AN:
152206
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00504
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.0354
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0288
Gnomad FIN
AF:
0.0386
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0294
Gnomad OTH
AF:
0.0224
GnomAD2 exomes
AF:
0.0231
AC:
2963
AN:
128418
AF XY:
0.0244
show subpopulations
Gnomad AFR exome
AF:
0.00473
Gnomad AMR exome
AF:
0.0108
Gnomad ASJ exome
AF:
0.0374
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0358
Gnomad NFE exome
AF:
0.0302
Gnomad OTH exome
AF:
0.0267
GnomAD4 exome
AF:
0.0268
AC:
13835
AN:
515626
Hom.:
249
Cov.:
0
AF XY:
0.0275
AC XY:
7691
AN XY:
279670
show subpopulations
African (AFR)
AF:
0.00540
AC:
82
AN:
15174
American (AMR)
AF:
0.0124
AC:
416
AN:
33504
Ashkenazi Jewish (ASJ)
AF:
0.0390
AC:
743
AN:
19054
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29302
South Asian (SAS)
AF:
0.0285
AC:
1755
AN:
61564
European-Finnish (FIN)
AF:
0.0379
AC:
1112
AN:
29372
Middle Eastern (MID)
AF:
0.0354
AC:
138
AN:
3900
European-Non Finnish (NFE)
AF:
0.0300
AC:
8845
AN:
295164
Other (OTH)
AF:
0.0260
AC:
744
AN:
28592
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
791
1583
2374
3166
3957
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0209
AC:
3181
AN:
152324
Hom.:
39
Cov.:
32
AF XY:
0.0217
AC XY:
1613
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00503
AC:
209
AN:
41578
American (AMR)
AF:
0.0156
AC:
238
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
123
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0290
AC:
140
AN:
4828
European-Finnish (FIN)
AF:
0.0386
AC:
410
AN:
10614
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0294
AC:
2002
AN:
68024
Other (OTH)
AF:
0.0217
AC:
46
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
171
342
514
685
856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0267
Hom.:
97
Bravo
AF:
0.0183
Asia WGS
AF:
0.0130
AC:
44
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 27, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24728327) -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.28
DANN
Benign
0.56
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35502837; hg19: chr22-24143573; COSMIC: COSV54093735; COSMIC: COSV54093735; API